These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35586986)

  • 1. PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.
    Simon V; Kota V; Bloomquist RF; Hanley HB; Forgacs D; Pahwa S; Pallikkuth S; Miller LG; Schaenman J; Yeaman MR; Manthei D; Wolf J; Gaur AH; Estepp JH; Srivastava K; Carreño JM; Cuevas F; ; Ellebedy AH; Gordon A; Valdez R; Cobey S; Reed EF; Kolhe R; Thomas PG; Schultz-Cherry S; Ross TM; Krammer F
    mSphere; 2022 Jun; 7(3):e0017922. PubMed ID: 35586986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.
    Kubale J; Gleason C; Carreño JM; Srivastava K; Singh G; ; Gordon A; Krammer F; Simon V
    mBio; 2022 Oct; 13(5):e0178422. PubMed ID: 35997286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
    Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
    Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
    Nordström P; Ballin M; Nordström A
    Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
    Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
    J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
    Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
    Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Antibodies against SARS-CoV-2: Importance of Comorbidities in Health Personnel against Reinfections.
    Vargas-De-León C; Cureño-Díaz MA; Salazar MI; Cruz-Cruz C; Loyola-Cruz MÁ; Durán-Manuel EM; Zamora-Pacheco ER; Bravata-Alcántara JC; Lugo-Zamudio GE; Fernández-Sánchez V; Bello-López JM; Ibáñez-Cervantes G
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.
    Soleimanian S; Alyasin S; Sepahi N; Ghahramani Z; Kanannejad Z; Yaghobi R; Karimi MH
    Front Immunol; 2022; 13():884879. PubMed ID: 35669767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
    Leidi A; Koegler F; Dumont R; Dubos R; Zaballa ME; Piumatti G; Coen M; Berner A; Darbellay Farhoumand P; Vetter P; Vuilleumier N; Kaiser L; Courvoisier D; Azman AS; Guessous I; Stringhini S;
    Clin Infect Dis; 2022 Mar; 74(4):622-629. PubMed ID: 34043763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological Markers of SARS-CoV-2 Reinfection.
    Siddiqui SM; Bowman KA; Zhu AL; Fischinger S; Beger S; Maron JS; Bartsch YC; Atyeo C; Gorman MJ; Yanis A; Hultquist JF; Lorenzo-Redondo R; Ozer EA; Simons LM; Talj R; Rankin DA; Chapman L; Meade K; Steinhart J; Mullane S; Siebert S; Streeck H; Sabeti P; Halasa N; Musk ER; Barouch DH; Menon AS; Nilles EJ; Lauffenburger DA; Alter G
    mBio; 2022 Feb; 13(1):e0214121. PubMed ID: 35073738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
    Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro.
    Penetra SLS; Santos HFP; Resende PC; Bastos LS; da Silva MFB; Pina-Costa A; Lopes RS; Saboia-Vahia L; de Oliveira ACA; Pereira EC; Filho FM; Wakimoto MD; Calvet GA; Fuller TL; Whitworth J; Smith C; Nielsen-Saines K; Carvalho MS; Espíndola OM; Guaraldo L; Siqueira MM; Brasil P
    J Infect Dis; 2023 Dec; 228(12):1680-1689. PubMed ID: 37571849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
    Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
    Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.
    Pilz S; Theiler-Schwetz V; Trummer C; Krause R; Ioannidis JPA
    Environ Res; 2022 Jun; 209():112911. PubMed ID: 35149106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil.
    Prete CA; Buss LF; Buccheri R; Abrahim CMM; Salomon T; Crispim MAE; Oikawa MK; Grebe E; da Costa AG; Fraiji NA; do P S S Carvalho M; Whittaker C; Alexander N; Faria NR; Dye C; Nascimento VH; Busch MP; Sabino EC
    BMC Infect Dis; 2022 Feb; 22(1):127. PubMed ID: 35123418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural immune response and protection from SARS-CoV-2 reinfection.
    Margiotti K; Fabiani M; Mesoraca A; Giorlandino C
    Acta Virol; 2021; 65(4):333-338. PubMed ID: 34796710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.